US Patent 11879125 GalNAc compositions for improving siRNA bioavailability
Patent 11879125 was granted and assigned to Empirico Inc. on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 30 Jan, 2024
Golden AI
Edits made to:
Infobox (+96 properties)
Article (+308 characters)
US Patent 11879125 GalNAc compositions for improving siRNA bioavailability
Article
Patent abstract
Provided herein, are compositions comprising GaINAc moieties that may be conjugated to an oligonucleotide. The oligonucleotide may be a small interfering RNA or an antisense oligonucleotide. Also provided herein are methods of treatment that include administering the composition to a subject.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Darren H. Wakefield0
David Rozema0
Omri Gottesman0
Date of Patent
January 23, 2024
0Patent Application Number
181845280
Date Filed
March 15, 2023
0Patent Citations
0
US Patent 8883752 5′ and 2′ BIS-substituted nucleosides and oligomeric compounds prepared therefrom
US Patent 8993738 Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
US Patent 9321799 Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
Patent Primary Examiner
Find more entities like US Patent 11879125 GalNAc compositions for improving siRNA bioavailability
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
